Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.
about
cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolaseAllergy and the cardiovascular systemAntioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewFunction of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase CPlatelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinOxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophagesPlatelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trialsTopographical body fat distribution links to amino acid and lipid metabolism in healthy obese women [corrected].Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.Role of cytokines and their inhibitors in acute pancreatitisSignaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells.In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes.Influence of interleukin 1alpha on superoxide anion, platelet activating factor release and phospholipase A2 activity of naive and sensitized guinea-pig alveolar macrophages.In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinPlatelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Preliminary Proteomic Analysis of A549 Cells Infected with Avian Influenza Virus H7N9 and Influenza A Virus H1N1Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls.Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor.Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosisThe Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.Platelet activating factor-induced expression of p21 is correlated with histone acetylationAMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis.Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation.Inhibition of lysoPAF acetyltransferase activity by flavonoids.Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth.Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells.The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells.Platelet-activating factor synthesis and receptor-mediated signaling are downregulated in ovine newborn lungs: relevance in postnatal pulmonary adaptation and persistent pulmonary hypertension of the newborn.Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue.Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization.Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients.Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode.
P2860
Q24336429-261C0A63-4CF3-41DD-B815-D74C8560ECC9Q24644929-DBBA002F-0C00-4198-B283-7C550A1326F9Q26991853-5E7D6E42-0D8F-4EB0-A88C-F2F1B2B0749FQ28141116-3F352257-C05A-4DE2-A254-5C791A870A41Q28343585-B126F165-E7A8-4E42-9BCB-C22EE9D04E09Q28348220-34535E1F-5851-4ECD-8FEC-FAD3738B3A86Q28539153-AC04EDF8-A134-446B-866A-EE09FAA55E8CQ31138912-9D8D96E6-CBCC-419B-B21C-C877957D326BQ33587302-F0A1F8E2-3245-434A-8D5A-B37D89D1EA1CQ33617636-71606B62-E35A-4321-B407-995D19F45165Q33655634-43C817D7-D20E-4CE3-BC4A-CB65A61BAC63Q33749579-5568A651-F0A6-4573-9B0F-3A17B985230BQ33805731-CDD989DB-F52B-4761-A604-133ABA24DE4EQ34178917-252484BA-DEEE-40FE-B93F-85D6AC1BC1D6Q35026939-0E247365-9888-452C-B241-E8119B3C88ADQ35183189-F04C5881-6F2F-43EA-9580-9EBF5C2022F0Q35621992-7145C1BE-E379-4EFD-9BD7-30C614885E31Q36029125-2E36769E-5565-451E-853C-D8247ED9DC41Q36230154-1E15E804-1A70-4C2E-9481-A8811CF04038Q36920166-5AE744FD-059A-4D87-B4F8-2E8743E99ED0Q37156655-A39A423E-FC5E-42A5-B686-E16486D7636FQ37196900-8E4B23C3-210B-4463-B102-F9F58FECF959Q37324462-944C9BD7-33D6-45B3-B44B-F65C3EF97324Q37364533-C2546239-6884-43F6-B408-BC9F4D62CC9AQ37374474-0607896B-5D6C-4E95-AC1A-1A4D262693EBQ37623684-10679152-2EE0-4A84-915E-B1D71DDFDF7BQ37734982-42799497-9C31-43B7-AD28-9CFE17D3C378Q38079764-246E0498-1EC3-4695-9CE0-4AF086F0373BQ41056352-4E65A1AE-F295-49FC-9033-E7223B1C582FQ41153392-AD5B40A6-8DD9-4F0E-B67A-1A571360F4F6Q41728384-68C21C28-4C85-4575-947D-AFB82D61B264Q41773351-1386705D-1126-42FA-ACDF-B2C70951D160Q42032125-E944D280-9415-43AC-9E5C-7311794060C8Q42440735-14B89CBA-802D-4F23-82D7-2B260482170FQ43442990-B35D03CF-7398-452D-A57B-2A4A60509041Q44503906-ED322EEE-A0BD-47FF-8770-500C60315ADAQ44516292-B88F6FE3-0246-40C0-8244-09F611DC29A1Q44536889-6C669897-1366-4615-8EE6-E81408CC403BQ44964344-E4BB9994-9B2A-4A8A-AEF9-8DF45DA25F58Q45328233-A6214423-4BEA-4379-A78A-33642766D5BB
P2860
Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Platelet-activating factor and ...... lated intracellular processes.
@en
type
label
Platelet-activating factor and ...... lated intracellular processes.
@en
prefLabel
Platelet-activating factor and ...... lated intracellular processes.
@en
P1476
Platelet-activating factor and ...... lated intracellular processes.
@en
P2093
P304
P356
10.1016/0005-2760(94)00192-2
P577
1995-02-01T00:00:00Z